Page last updated: 2024-08-18

carbitol and Breast Neoplasms

carbitol has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kohli, K; Mangla, B; Neupane, YR; Singh, A; Sonali, LJ; Soni, NK1
Datta, D; Dave, KM; Gayen, JR; Gupta, AP; Mitra, K; Riyazuddin, M; Singh, A; Syed, AA; Valicherla, GR1

Other Studies

2 other study(ies) available for carbitol and Breast Neoplasms

ArticleYear
Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment.
    Nanotechnology, 2020, Nov-20, Volume: 31, Issue:47

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Drug Carriers; Ethylene Glycols; Fatty Acids; Female; Humans; MCF-7 Cells; Nanostructures; Raloxifene Hydrochloride; Rats, Wistar; Selective Estrogen Receptor Modulators

2020
Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity.
    Scientific reports, 2016, 05-31, Volume: 6

    Topics: Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Cell Survival; Docetaxel; Drug Compounding; Drug Delivery Systems; Drug Stability; Emulsions; Ethylene Glycols; Female; Humans; Male; MCF-7 Cells; Mice, Inbred BALB C; Polyethylene Glycols; Polymers; Propylene Glycols; Rats; Rats, Sprague-Dawley; Solubility; Taxoids; Vitamin E; Xenograft Model Antitumor Assays

2016